Wird geladen...
Next-generation prognostic assessment for diffuse large B-cell lymphoma
Current standard of care therapy for diffuse large B-cell lymphoma (DLBCL) cures a majority of patients with additional benefit in salvage therapy and autologous stem cell transplant for patients who relapse. The next generation of prognostic models for DLBCL aims to more accurately stratify patient...
Gespeichert in:
| Veröffentlicht in: | Future Oncol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4644669/ https://ncbi.nlm.nih.gov/pubmed/26289217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.15.144 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|